Schedule 13G ownership disclosure

WEST PHARMACEUTICAL SVSC INC COM

Common Stock · CUSIP: 955306105

Event date: 2025-03-31

Filing-level shares
6,066,852
Percent of class
8.4%
  • BlackRock, Inc.

    Shares: 6,066,852 · Class: 8.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002052113-25-001665
Form type
SCHEDULE 13G/A
Filer
BlackRock, Inc.
CIK
CIK 2012383
Filed
Apr 24, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub